Analyst Ratings for Vanda Pharmaceuticals (VNDA)
VNDA Rating Summary
VNDA Price Target Summary
- Highest: $24.00 (H.C. Wainwright)
- Lowest: $7.50 (Jefferies)
- Average: $15.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$15.50 (+96.5%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
Avg. $ Target:
$15.50 (+96.5%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2026 | Truist Securities | Lee Sulewski | New Coverage | Buy (N/A) |
18.00 (N/A) |
8.20 (7.89) |
-3.78% | Details |
| 11/5/2025 | B.Riley » Updated 2/25/2026 |
Madison El-Saadi | New Coverage | Buy (N/A) |
17.00 (14.00) |
4.47 (7.89) |
76.51% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
